• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB
Click for more information
4.48% 32.0¢

DIMERIX LIMITED

Market Cap $175.8M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing new therapies in areas with unmet medical needs for global markets. It is focused on developing its products, DMX-200, for Focal Segmental Glomerulosclerosis (FSGS), respiratory complications associated with COVID-19 and Diabetic Kidney Disease and is developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its DMX-200 and DMX-700 are identified using its assay, Receptor Heteromer Investigation Technology (Receptor-HIT), which is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. It has completed two Phase 2 studies: one in FSGS and one in diabetic kidney disease. Receptor-HIT is licensed to Excellerate Bioscience.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DXB
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference 		27/04/24 34 8.4K
27/04/24 Last post  finfreeblog Comments Created with Sketch.  34  Views Created with Sketch.  8.4K 
DXB
Dimerix (ASX: DXB) Discussion Thread
9 10 11
26/04/24 626 197K
26/04/24 Last post  TheBrownHornet Comments Created with Sketch.  626  Views Created with Sketch.  197K 
DXB
DJ Dimerix Initiated at A$0.80/Share Price Target by Euroz Hartleys 		26/04/24 11 4.5K
26/04/24 Last post  TheBrownHornet Comments Created with Sketch.  11  Views Created with Sketch.  4.5K 
DXB
DXB Chart
12 13 14
25/04/24 806 274K
25/04/24 Last post  RYNZN Comments Created with Sketch.  806  Views Created with Sketch.  274K 
DXB
Ann: Quarterly Appendix 4C and Activities Report 		24/04/24 48 13K
24/04/24 Last post  kdwc Comments Created with Sketch.  48  Views Created with Sketch.  13K 
DXB
Ann: Application for quotation of securities - DXB 		22/04/24 0 375
22/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  375 
DXB
Ann: Notification of cessation of securities - DXB 		13/04/24 2 1.3K
13/04/24 Last post  frenchfries57 Comments Created with Sketch.  2  Views Created with Sketch.  1.3K 
DXB
Ann: Application for quotation of securities - DXB 		10/04/24 0 368
10/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  368 

See All Discussions arrow Created with Sketch.

Timeline

Application for quotation of securities - DXB
22 Apr 11:21
 
Quarterly Appendix 4C and Activities Report
22 Apr 08:45
 
Notification of cessation of securities - DXB
12 Apr 10:26
 
Application for quotation of securities - DXB
10 Apr 10:37
 
Change of Director's Interest Notice - SP
08 Apr 13:28
 
Notification of cessation of securities - DXB
05 Apr 08:59
 
View More arrow Created with Sketch.

Featured News

CC9 Chariot ends quarter charged up on lithium find in Wyoming
right-arrow Created with Sketch.
BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.
ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.

(20min delay)
Last
32.0¢ 		Change
-0.015(4.48%) 		Mkt cap ! $175.8M
Open High Low Value Volume
33.0¢ 33.5¢ 31.5¢ $1.333M 4.143M

Buyers (Bids)

No. Vol. Price($)
1 727594 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 170412 4
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
32.0¢ 		  Change
-0.015 ( 3.15 %)
Open High Low Volume
33.5¢ 33.5¢ 31.5¢ 2261030
Last updated 15.51pm 26/04/2024 ?
DXB (ASX) Chart

Top Stories

Week 17 Wrap: BHP-Anglo deal helps push down ASX; US data of concern but AI bulls happy

The big thematics and headlines that drove the ASX this week, plus, the headlines I think investors ought to be keeping eyes on.
Crypto world awaits overnight Bitcoin halving event The four-yearly Bitcoin halving is set to happen in the early hours of tomorrow morning (Saturday, April 20) - it's an event that industry leader Swyftx likened to 'the Olympic Games for the crypto industry'.
1970s on repeat, but there's a silver lining! ABBA fans across Australia know that the 1970s were not only about nervous shuffles to the strains of Dancing Queen, across the linoleum floor at the local Blue Light Disco. Oil had only recently begun to rise, and so synthetic fabrics, like polyester, were very popular. So was central heating, using fuel oil. This is all ancient history now and it would not matter except for the fact that history is now rhyming so hard.
BHP confirms £31.1B takeover bid for Anglo American BHP HAS confirmed its offer to takeover fellow mining giant Anglo American plc, following press speculation of a potential deal.which had unsettled shareholder groups and financial firms in London, and provoked criticism from a South African government minister.
Recce Pharmaceuticals up 6% on new antibiotic production milestone Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.

Featured News

NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.
CC9 Chariot ends quarter charged up on lithium find in Wyoming
right-arrow Created with Sketch.
BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.